Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil and recurrence of acute urinary retention
PACTR202305669258195Phase 2Completed
- Sponsor
- Ahmed Loghmari
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tadalafil and silodosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Ahmed Loghmari. Started Jun 2020; status: completed.
02
Drugs
tadalafilsilodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on PACTR202305669258195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202305669258195.